Abstract
Asthma is a lung inflammation disease caused by a complex interaction between the immune system and environmental factors such as allergens. A lot of research is being done on discovering new proteins and post translational modification (PTM) associated with asthma pathogenesis. This chapter illustrates updated approaches in proteins and PTM detection and associating biomarkers of asthma. We focus on approaches such as Mass Spectrometry (MS), NMR, and microarray platforms. Concepts of protein and PTMs may provide new insights in searching potential clinical biomarkers in asthma.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Laitinen L, Heino M, Laitinen A, Kava T, Haahtela T. Damage of the airway epithelium and bronchial reactivity in patients with asthma 1–3. Am Rev Respir Dis. 1985;131:599–606. [Pubmed: 3994155]
Lee J-Y, Park S-W, Chang HK, Kim HY, Rhim T, Lee J-H, et al. A disintegrin and metalloproteinase 33 protein in patients with asthma: relevance to airflow limitation. Am J Respir Crit Care Med. 2006;173(7):729–35. [Pubmed:16387804]
Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol. 2004;22:789–815. [Pubmed:15032597]
O’Neil SE, Sitkauskiene B, Babusyte A, Krisiukeniene A, Stravinskaite-Bieksiene K, Sakalauskas R, et al. Network analysis of quantitative proteomics on asthmatic bronchi: effects of inhaled glucocorticoid treatment. Respir Res. 2011;12:124. [Pubmed:21939520]
Park C-S, Rhim T. Application of proteomics in asthma research. Expert Rev Proteomics. 2011;8:221–30. [Pubmed:21501015]
Huang Y, Min S, Lui Y, Sun J, Su X, Liu Y, et al. Global mapping of H3K4me3 and H3K27me3 reveals chromatin state-based regulation of human monocyte-derived dendritic cells in different environments. Genes Immun. 2012;13:311–20. [Pubmed:22278394]
Cuddapah S, Barski A, Zhao K. Epigenomics of T cell activation, differentiation, and memory. Curr Opin Immunol. 2010;22:341–7. [Pubmed:20226645]
Seumois G, Chavez L, Gerasimova A, Lienhard M, Omran N, Kalinke L, et al. Epigenomic analysis of primary human T cells reveals enhancers associated with TH2 memory cell differentiation and asthma susceptibility. Nat Immunol. 2014;15:777–88. [Pubmed:24997565]
Hew M, Bhavsar P, Torrego A, Meah S, Khorasani N, Barnes PJ, et al. Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. Am J Respir Crit Care Med. 2006;174:134–41. [Pubmed:16614347]
Wang Z, DiDonato JA, Buffa J, Comhair SA, Aronica MA, Dweik RA, et al. Eosinophil peroxidase catalyzed protein carbamylation participates in asthma. J Biol Chem. 2016;291:22118–35. [Pubmed:27587397]
Agache I, Akdis CA. Endotypes of allergic diseases and asthma: an important step in building blocks for the future of precision medicine. Allergol Int. 2016;65:243–52. [Pubmed:27282212]
Toda M, Ono SJ. Genomics and proteomics of allergic disease. Immunology. 2002;106:1–10. [Pubmed:11972626]
Baskin Y, Yigitbasi T. Clinical proteomics of breast cancer. Curr Genomics. 2010;11:528–36. [Pubmed:21532837]
Ahn SM, Simpson RJ. Body fluid proteomics: prospects for biomarker discovery. Proteomics Clin Appl. 2007;1:1004–15. [Pubmed:21136753]
Plymoth A, Löfdahl CG, Ekberg-Jansson A, Dahlbäck M, Lindberg H, Fehniger TE, et al. Human bronchoalveolar lavage: biofluid analysis with special emphasis on sample preparation. Proteomics. 2003;3:962–72. [Pubmed:12833521]
Lindahl M, Ståhlbom B, Tagesson C. Newly identified proteins in human nasal and bronchoalveolar lavage fluids: potential biomedical and clinical applications. Electrophoresis. 1999;20:3670–6. [Pubmed:10612294]
Kim TH, Lee YH, Kim KH, Lee SH, Cha JY, Shin EK, et al. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis. Am J Respir Crit Care Med. 2010;182:633–42. [Pubmed:20463180]
Murphy VE, Johnson RF, Wang Y-C, Akinsanya K, Gibson PG, Smith R, et al. The effect of maternal asthma on placental and cord blood protein profiles. J Soc Gynecol Investig. 2005;12:349–55. [Pubmed:15979547]
Lee S-H, Rhim T, Choi Y-S, Min J-W, Kim S-H, Cho S-Y, et al. Complement C3a and C4a increased in plasma of patients with aspirin-induced asthma. Am J Respir Crit Care Med. 2006;173:370–8. [Pubmed:16293803]
Samter M, Beers RF. Concerning the nature of intolerance to aspirin. J Allergy. 1967;40:281–93. [Pubmed:5235203]
Szczeklik A, Gryglewski R, Czerniawska-Mysik G. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br Med J. 1975;1:67–9. [Pubmed:1109660]
Cowburn AS, Sladek K, Soja J, Adamek L, Nizankowska E, Szczeklik A, et al. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest. 1998;101:834–46. [Pubmed:9466979]
Rhim T, Choi YS, Nam BY, Uh S, Park J, Kim YH, et al. Plasma protein profiles in early asthmatic responses to inhalation allergen challenge. Allergy. 2009;64:47–54. [Pubmed:19076930]
Houtman R, Krijgsveld J, Kool M, Romijn EP, Redegeld FA, Nijkamp FP, et al. Lung proteome alterations in a mouse model for nonallergic asthma. Proteomics. 2003;3:2008–18. [Pubmed:14625863]
Jeong H, Rhim T, Ahn M-H, Yoon P-O, Kim S-H, Chung IY, et al. Proteomic analysis of differently expressed proteins in a mouse model for allergic asthma. J Korean Med Sci. 2005;20:579–85. [Pubmed:16100449]
Zhao J, Zhu H, Wong CH, Leung KY, Wong W. Increased lungkine and chitinase levels in allergic airway inflammation: a proteomics approach. Proteomics. 2005;5:2799–807. [Pubmed:15996009]
Calvo FQ, Fillet M, De Seny D, Meuwis MA, Marée R, Crahay C, et al. Biomarker discovery in asthma-related inflammation and remodeling. Proteomics. 2009;9:2163–70. [Pubmed:19322781]
Roh GS, Shin Y, Seo SW, Yoon BR, Yeo S, Park SJ, et al. Proteome analysis of differential protein expression in allergen-induced asthmatic mice lung after dexamethasone treatment. Proteomics. 2004;4:3318–27. [Pubmed:15378748]
Liu H, Zhou L-F, Zhang Q, Qian F-H, Yin K-S, Huang M, et al. Increased RhoGDI~ 2 and peroxiredoxin 5 levels in asthmatic murine model of beta~ 2-adrenoceptor desensitization: a proteomics approach. Chin Med J. 2008;121:355–62. [Pubmed:18304470]
Zhu Z, Zheng T, Homer RJ, Kim Y-K, Chen NY, Cohn L, et al. Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science. 2004;304:1678–82. [Pubmed:15192232]
Zhou Y, Dong Q, Louahed J, Dragwa C, Savio D, Huang M, et al. Characterization of a calcium-activated chloride channel as a shared target of Th2 cytokine pathways and its potential involvement in asthma. Am J Respir Cell Mol Biol. 2001;25:486–91. [Pubmed:11694454]
Michel O, Doyen V, Leroy B, Bopp B, Dinh DHP, Corazza F, et al. Expression of calgranulin A/B heterodimer after acute inhalation of endotoxin: proteomic approach and validation. BMC Pulm Med. 2013;13:65–72. [Pubmed:24237763]
Zimmermann N, King NE, Laporte J, Yang M, Mishra A, Pope SM, et al. Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest. 2003;111:1863–74. [Pubmed:16100447]
Shi O, Morris SM, Zoghbi H, Porter CW, O’Brien WE. Generation of a mouse model for arginase II deficiency by targeted disruption of the arginase II gene. Mol Cell Biol. 2001;21:811–3. [Pubmed:11154268]
Barnes FA, Bingle L, Bingle CD. Pulmonary genomics, proteomics, and PLUNCs. Am J Respir Cell Mol Biol. 2008;38:377–9. [Pubmed:17975173]
Ghafouri B, Irander K, Lindbom J, Tagesson C, Lindahl M. Comparative proteomics of nasal fluid in seasonal allergic rhinitis. J Proteome Res. 2006;5:330–8. [Pubmed:16457599]
Wu J, Kobayashi M, Sousa EA, Liu W, Cai J, Goldman SJ, et al. Differential proteomic analysis of bronchoalveolar lavage fluid in asthmatics following segmental antigen challenge. Mol Cell Proteomics. 2005;4:1251–64. [Pubmed:15951573]
North ML, Khanna N, Marsden PA, Grasemann H, Scott JA. Functionally important role for arginase 1 in the airway hyperresponsiveness of asthma. Am J Physiol Lung Cell Mol Physiol. 2009;296:L911–L20. [Pubmed:19286931]
Greenlee KJ, Corry DB, Engler DA, Matsunami RK, Tessier P, Cook RG, et al. Proteomic identification of in vivo substrates for matrix metalloproteinases 2 and 9 reveals a mechanism for resolution of inflammation. J Immunol. 2006;177:7312–21. [Pubmed:17082650]
Louten J, Mattson JD, Malinao M-C, Li Y, Emson C, Vega F, et al. Biomarkers of disease and treatment in murine and cynomolgus models of chronic asthma. Biomark Insights. 2012;7:87–104. [Pubmed:22837640]
Lee T-H, Jang A-S, Park J-S, Kim T-H, Choi YS, Shin H-R, et al. Elevation of S100 calcium binding protein A9 in sputum of neutrophilic inflammation in severe uncontrolled asthma. Ann Allergy Asthma Immunol. 2013;111:268–75. [Pubmed:24054362]
Yan X, Chu J-H, Gomez J, Koenigs M, Holm C, He X, et al. Noninvasive analysis of the sputum transcriptome discriminates clinical phenotypes of asthma. Am J Respir Crit Care Med. 2015;191:1116–25. [Pubmed:25763605]
Candiano G, Bruschi M, Pedemonte N, Caci E, Liberatori S, Bini L, et al. Gelsolin secretion in interleukin-4–treated bronchial epithelia and in asthmatic airways. Am J Respir Crit Care Med. 2005;172:1090–6. [Pubmed:16100010]
Larsen K, Macleod D, Nihlberg K, Gürcan E, Bjermer L, Marko-Varga G, et al. Specific haptoglobin expression in bronchoalveolar lavage during differentiation of circulating fibroblast progenitor cells in mild asthma. J Proteome Res. 2006;5:1479–83. [Pubmed:16739999]
Jeong HC, Lee SY, Lee EJ, Jung KH, Kang EH, Lee SY, et al. Proteomic analysis of peripheral T-lymphocytes in patients with asthma. Chest. 2007;132:489–96. [Pubmed:17550934]
Gray RD, MacGregor G, Noble D, Imrie M, Dewar M, Boyd AC, et al. Sputum proteomics in inflammatory and suppurative respiratory diseases. Am J Respir Crit Care Med. 2008;178:444–52. [Pubmed:18565957]
Hur G-Y, Choi G-S, Sheen S-S, Lee H-Y, Park H-J, Choi S-J, et al. Serum ferritin and transferrin levels as serologic markers of methylene diphenyl diisocyanate–induced occupational asthma. J Allergy Clin Immunol. 2008;122:774–80. [Pubmed:191014769]
Gomes-Alves P, Imrie M, Gray RD, Nogueira P, Ciordia S, Pacheco P, et al. SELDI-TOF biomarker signatures for cystic fibrosis, asthma and chronic obstructive pulmonary disease. Clin Biochem. 2010;43:168–77. [Pubmed:19850022]
Gharib SA, Nguyen EV, Lai Y, Plampin JD, Goodlett DR, Hallstrand TS. Induced sputum proteome in healthy subjects and asthmatic patients. J Allergy Clin Immunol. 2011;128:1176–84. [Pubmed:21906793]
Verrills NM, Irwin JA, Yan He X, Wood LG, Powell H, Simpson JL, et al. Identification of novel diagnostic biomarkers for asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011;183:1633–43. [Pubmed:21471098]
Haenen S, Clynen E, Nemery B, Hoet PH, Vanoirbeek JA. Biomarker discovery in asthma and COPD: application of proteomics techniques in human and mice. EuPA Open Proteom. 2014;4:101–12. https://doi.org/10.1016/j.euprot.2014.04.008
Karve TM, Cheema AK. Small changes huge impact: the role of protein posttranslational modifications in cellular homeostasis and disease. J Amino Acids. 2011;2011:207691–9. [Pubmed:22312457]
Walsh CT, Garneau-Tsodikova S, Gatto GJ. Protein posttranslational modifications: the chemistry of proteome diversifications. Angew Chem Int Ed Eng. 2005;44:7342–72. [Pubmed:16267872]
Theillet F-X, Smet-Nocca C, Liokatis S, Thongwichian R, Kosten J, Yoon M-K, et al. Cell signaling, post-translational protein modifications and NMR spectroscopy. J Biomol NMR. 2012;54:217–36. [Pubmed:23011410]
Chou T-Y, Hart GW. O-linked N-acetylglucosamine and cancer: messages from the glycosylation of c-Myc. The molecular immunology of complex carbohydrates—2. Adv Exp Med Biol. 2001;491:413–8. [Pubmed:14533811]
Stenflo J, Fernlund P, Egan W, Roepstorff P. Vitamin K dependent modifications of glutamic acid residues in prothrombin. Proc Natl Acad Sci U S A. 1974;71:2730–3. [Pubmed:4528109]
Nesvizhskii AI. Protein identification by tandem mass spectrometry and sequence database searching. Methods Mol Biol. 2007;367:87–119. [Pubmed:17185772]
Kuhn E, Addona T, Keshishian H, Burgess M, Mani D, Lee RT, et al. Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry. Clin Chem. 2009;55:1108–17. [Pubmed:19372185]
Villén J, Gygi SP. The SCX/IMAC enrichment approach for global phosphorylation analysis by mass spectrometry. Nat Protoc. 2008;3:1630–8. [Pubmed:18833199]
Gruhler A, Olsen JV, Mohammed S, Mortensen P, Færgeman NJ, Mann M, et al. Quantitative phosphoproteomics applied to the yeast pheromone signaling pathway. Mol Cell Proteomics. 2005;4:310–27. [Pubmed:15665377]
FÃla J, Honys D. Enrichment techniques employed in phosphoproteomics. Amino Acids. 2012;43:1025–47. [Pubmed:22002794]
Larsen MR, Trelle MB, Thingholm TE, Jensen ON. Analysis of posttranslational modifications of proteins by tandem mass spectrometry. Biotechniques. 2006;40:790–8. [Pubmed:16774123]
Oberg AL, Vitek O. Statistical design of quantitative mass spectrometry-based proteomic experiments. J Proteome Res. 2009;8:2144–56. [Pubmed:19222236]
Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature. 2003;422:198–207. [Pubmed:12634793]
Cai W, Tucholski TM, Gregorich ZR, Ge Y. Top-down proteomics: technology advancements and applications to heart diseases. Expert Rev Proteomics. 2016;13:717–30. [Pubmed:27448560]
Amunugama R, Jones R, Ford M, Allen D. Bottom-up mass spectrometry–based proteomics as an investigative analytical tool for discovery and quantification of proteins in biological samples. Adv Wound Care. 2013;2:549–57. [Pubmed:24761338]
Zannetos S, Zachariadou T, Zachariades A, Georgiou A, Talias MA. The economic burden of adult asthma in Cyprus; a prevalence-based cost of illness study. BMC Public Health. 2017;17:262–71. [Pubmed:28302094]
Giron P, Dayon L, Sanchez JC. Cysteine tagging for MS-based proteomics. Mass Spectrom Rev. 2011;30:366–95. [Pubmed:21500242]
Ong S-E, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A, et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics. 2002;1:376–86. [Pubmed:12118079]
Farley AR, Link AJ. Identification and quantification of protein posttranslational modifications. Methods Enzymol. 2009;463:725–63. [Pubmed:19892200]
McLafferty FW, Horn DM, Breuker K, Ge Y, Lewis MA, Cerda B, et al. Electron capture dissociation of gaseous multiply charged ions by Fourier-transform ion cyclotron resonance. J Am Soc Mass Spectrom. 2001;12:245–9. [Pubmed:11281599]
Wells JM, McLuckey SA. Collision-induced dissociation (CID) of peptides and proteins. Methods Enzymol. 2005;402:148–85. [Pubmed:16401509]
Han J, Borchers CH. Top-down analysis of recombinant histone H3 and its methylated analogs by ESI/FT-ICR mass spectrometry. Proteomics. 2010;10(20):3621–30. [Pubmed:20486121]
Catherman AD, Skinner OS, Kelleher NL. Top down proteomics: facts and perspectives. Biochem Biophys Res Commun. 2014;445:683–93. [Pubmed:24556311]
Halim A, Carlsson MC, Madsen CB, Brand S, Moller SR, Olsen CE, et al. Glycoproteomic analysis of seven major allergenic proteins reveals novel post-translational modifications. Mol Cell Proteomics. 2015;14:191–204. [Pubmed:25389185]
Safaei A, Rezaei-Tavirani M, Oskouie AA, Mohebbi SR, Shabani M, Sharifian A. Serum metabolic profiling of advanced cirrhosis based on HCV. Hepat Mon. 2017;17:e44431.
Schubert M, Walczak MJ, Aebi M, Wider G. Posttranslational modifications of intact proteins detected by NMR spectroscopy: application to glycosylation. Angew Chem Int Ed Eng. 2015;127:7202–6. [Pubmed:25924827]
Lu KP, Zhou XZ. The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat Rev Mol Cell Biol. 2007;8:904–16. [Pubmed:17878917]
Thomas MA, Buelow BJ, Nevins AM, Jones SE, Peterson FC, Gundry RL, et al. Structure-function analysis of CCL28 in the development of post-viral asthma. J Biol Chem. 2015;290:4528–36. [Pubmed:25556652]
Espina V, Woodhouse EC, Wulfkuhle J, Asmussen HD, Petricoin EF, Liotta LA. Protein microarray detection strategies: focus on direct detection technologies. J Immunol Methods. 2004;290:121–33. [Pubmed:15261576]
Berrade L, Garcia AE, Camarero JA. Protein microarrays: novel developments and applications. Pharm Res. 2011;28:1480–99. [Pubmed:21116694]
Merbl Y, Kirschner MW. Protein microarrays for genome-wide posttranslational modification analysis. Wiley Interdiscip Rev Syst Biol Med. 2011;3:347–56. [Pubmed:20865779]
Zimmermann N, King NE, Laporte J, Yang M, Mishra A, Pope SM, et al. Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest. 2003;111:1863–74. [Pubmed:12813022]
Kim H-B, Kim C-K, Iijima K, Kobayashi T, Kita H. Protein microarray analysis in patients with asthma: elevation of the chemokine PARC/CCL18 in sputum. Chest. 2009;135:295–302. [Pubmed:19017877]
Woodruff PG, Boushey HA, Dolganov GM, Barker CS, Yang YH, Donnelly S, et al. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci U S A. 2007;104:15858–63. [Pubmed:17898169]
Lee JH, Kaminski N, Dolganov G, Grunig G, Koth L, Solomon C, et al. Interleukin-13 induces dramatically different transcriptional programs in three human airway cell types. Am J Respir Cell Mol Biol. 2001;25:474–85. [Pubmed:11694453]
Yuyama N, Davies DE, Akaiwa M, Matsui K, Hamasaki Y, Suminami Y, et al. Analysis of novel disease-related genes in bronchial asthma. Cytokine. 2002;19:287–96. [Pubmed:12421571]
Wang S-W, Oh CK, Cho SH, Hu G, Martin R, Demissie-Sanders S, et al. Amphiregulin expression in human mast cells and its effect on the primary human lung fibroblasts. J Allergy Clin Immunol. 2005;115:287–94. [Pubmed:15966083]
Karp CL, Grupe A, Schadt E, Ewart SL, Keane-Moore M, Cuomo PJ, et al. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat Immunol. 2000;1:221–6. [Pubmed:10973279]
Zou J, Young S, Zhu F, Gheyas F, Skeans S, Wan Y, et al. Microarray profile of differentially expressed genes in a monkey model of allergic asthma. Genome Biol. 2002;3(5):research0020. [Pubmed:12049661]
Izuhara K, Saito H. Microarray-based identification of novel biomarkers in asthma. Allergol Int. 2006;55:361–7. [Pubmed:17130677]
Takayama G, Arima K, Kanaji T, Toda S, Tanaka H, Shoji S, et al. Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol. 2006;118:98–104. [Pubmed:16815144]
Barabasi A-L, Oltvai ZN. Network biology: understanding the cell’s functional organization. Nat Rev Genet. 2004;5:101–13. [Pubmed:14735121]
Peyvandi AA, Khoshsirat S, Safaei A, Rezaei-Tavirani M, Azodi-Zamanian M. Interactome analysis of 11-dehydrosinulariolide-treated oral carcinoma cell lines such as Ca9-22 and CAL-27 and melanoma cell line. Inter J Cancer Manag. 2017;10:e10096. http://ijcancerprevention.com/en/articles/10096.html
Safaei A, Tavirani MR, Azodi MZ, Lashay A, Mohammadi SF, Broumand MG, et al. Diabetic retinopathy and laser therapy in rats: a protein-protein interaction network analysis. J Lasers Med Sci. 2017;8:S20–1. [Pubmed:29071030]
Abbaszadeh H-A, Peyvandi AA, Sadeghi Y, Safaei A, Zamanian-Azodi M, Khoramgah MS, et al. Er: YAG laser and cyclosporin A effect on cell cycle regulation of human gingival fibroblast cells. J Lasers Med Sci. 2017;8(3):143–9. [Pubmed:29123635]
Ardakani MJE, Safaei A, Oskouie AA, Haghparast H, Haghazali M, Shalmani HM, et al. Evaluation of liver cirrhosis and hepatocellular carcinoma using Protein-Protein Interaction Networks. Gastroenterol Hepatol Bed Bench. 2016;9:S14–22. [Pubmed:28224023]
Safaei A, Tavirani MR, Oskouei AA, Azodi MZ, Mohebbi SR, Nikzamir AR. Protein-protein interaction network analysis of cirrhosis liver disease. Gastroenterol Hepatol Bed Bench. 2016;9(2):114–23. [Pubmed:27099671]
Kann MG. Protein interactions and disease: computational approaches to uncover the etiology of diseases. Brief Bioinform. 2007;8:333–46. [Pubmed:17638813]
Shoemaker BA, Panchenko AR, Bryant SH. Finding biologically relevant protein domain interactions: conserved binding mode analysis. Protein Sci. 2006;15:352–61. [Pubmed:16385001]
Kuzmanov U, Emili A. Protein-protein interaction networks: probing disease mechanisms using model systems. Genome Med. 2013;5:37. [Pubmed:23635424]
Chen Y, Qiao J. Protein–protein interaction network analysis and identifying regulation microRNAs in asthmatic children. Allergol Immunopathol. 2015;43:584–92. [Pubmed:25979194]
Xu W. Expression data analysis to identify biomarkers associated with asthma in children. Int J Genomics. 2014;2014:165175. [Pubmed:24790987]
Smith LD, Leatherbarrow RJ, Spivey AC. Development of small molecules to target the IgE: FcεRI protein–protein interaction in allergies. Future Med Chem. 2013;5:1423–35. [Pubmed:23919552]
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Safaei, A., Oskouie, A.A. (2018). Protein and Post Translational Modification in Asthma. In: Wang, X., Chen, Z. (eds) Genomic Approach to Asthma. Translational Bioinformatics, vol 12. Springer, Singapore. https://doi.org/10.1007/978-981-10-8764-6_6
Download citation
DOI: https://doi.org/10.1007/978-981-10-8764-6_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-8763-9
Online ISBN: 978-981-10-8764-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)